Next Article in Journal
Transcriptome and Network Analyses Reveal the Gene Set Involved in PST Accumulation and Responses to Toxic Alexandrium minutum Exposure in the Gills of Chlamys farreri
Next Article in Special Issue
Role of Polymer Concentration on the Release Rates of Proteins from Single- and Double-Network Hydrogels
Previous Article in Journal
Shape Transformations and Self-Assembly of Hairy Particles under Confinement
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Design, Characterization, and Antibacterial Performance of MAPLE-Deposited Coatings of Magnesium Phosphate-Containing Silver Nanoparticles in Biocompatible Concentrations

by
Denisa Alexandra Florea
1,
Valentina Grumezescu
2,
Alexandra Cătălina Bîrcă
1,
Bogdan Ștefan Vasile
1,
Mihaela Mușat
1,
Cristina Chircov
1,
Miruna S. Stan
3,4,
Alexandru Mihai Grumezescu
1,3,5,
Ecaterina Andronescu
1,5,* and
Mariana Carmen Chifiriuc
5,6,7
1
Department of Science and Engineering of Oxide Materials and Nanomaterials, Politehnica University of Bucharest, 011061 Bucharest, Romania
2
National Institute for Lasers, Plasma and Radiation Physics, 409 Atomistilor Street, 077125 Magurele, Romania
3
Research Institute of the University of Bucharest (ICUB), University of Bucharest, 050657 Bucharest, Romania
4
Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania
5
Academy of Romanian Scientists, Ilfov No. 3, 050044 Bucharest, Romania
6
Department of Microbiology, Faculty of Biology, University of Bucharest, Aleea Portocalelor Str. 1-3, District 5, 060101 Bucharest, Romania
7
The Romanian Academy, Calea Victoriei 25, District 1, 010071 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(14), 7910; https://doi.org/10.3390/ijms23147910
Submission received: 22 June 2022 / Revised: 15 July 2022 / Accepted: 16 July 2022 / Published: 18 July 2022
(This article belongs to the Special Issue Recent Advances on Multifunctional Bioscaffolds)

Abstract

:
Bone disorders and traumas represent a common type of healthcare emergency affecting men and women worldwide. Since most of these diseases imply surgery, frequently complicated by exogenous or endogenous infections, there is an acute need for improving their therapeutic approaches, particularly in clinical conditions requiring orthopedic implants. Various biomaterials have been investigated in the last decades for their potential to increase bone regeneration and prevent orthopedic infections. The present study aimed to develop a series of MAPLE-deposited coatings composed of magnesium phosphate (Mg3(PO4)2) and silver nanoparticles (AgNPs) designed to ensure osteoblast proliferation and anti-infective properties simultaneously. Mg3(PO4)2 and AgNPs were obtained through the cooling bath reaction and chemical reduction, respectively, and then characterized through X-ray Diffraction (XRD), Transmission Electron Microscopy (TEM), and Selected Area Electron Diffraction (SAED). Subsequently, the obtained coatings were evaluated by Infrared Microscopy (IRM), Fourier-Transform Infrared Spectroscopy (FT-IR), and Scanning Electron Microscopy (SEM). Their biological properties show that the proposed composite coatings exhibit well-balanced biocompatibility and antibacterial activity, promoting osteoblasts viability and proliferation and inhibiting the adherence and growth of Staphylococcus aureus and Pseudomonas aeruginosa, two of the most important agents of orthopedic implant-associated infections.

1. Introduction

Bone tissue diseases are a very common type of disorder, affecting men and women worldwide and accounting for half of all chronic conditions in people over 50 years [1,2]. Bone fractures represent both a category or a primary consequence of other bone disorders, occurring especially by incomplete bone healing and/or inefficient bone regeneration [3]. Orthopedic surgery is often inevitable, but unfortunately, it further leads to severe side effects, such as associated infections, nerve injuries, chronic pain, and morbidity. Therefore, developing more efficient solutions in terms of functionality and economic aspects is crucial. Various synthetic and natural biomaterials have been investigated in the last decades to minimize the drawbacks of currently available orthopedic treatments and to reduce the risk of a second surgery due to infection (associated with biofilm formation, bone, and soft tissue necrosis, bone matrix destruction) or other related complications [4]. Biomaterials could exhibit antimicrobial activities per se or by providing the local release of antibiotics, modulating the local inflammatory reaction, promoting osteoblast proliferation and bone tissue regeneration, or be used as a bone defect filler after debridement surgery [5].
Among the numerous biomaterials designed for orthopedic applications, ceramics represent promising candidates, providing suitable structures, porosities, mechanical properties, degradation rates, and antimicrobial features. Besides the well-known hydroxyapatite, fluoroapatite, β-tricalcium phosphate, and other bioactive glasses, magnesium phosphate (Mg3(PO4)2) has received increasing attention for orthopedic applications due to its good biocompatibility, suitable mechanical properties, and high biodegradability [6,7,8,9,10].
Thus, magnesium-based bioceramics are used to develop cements, macroporous scaffolds, and coatings [11]. Together with calcium, potassium, and sodium, magnesium ions are among the most abundant ions within the human body, exhibiting multiple functions, e.g., DNA stabilization, enzymatic activation, stimulation of cellular growth, and proliferation [12,13,14]. Furthermore, there are multiple advantages to using magnesium over calcium phosphate in the orthopedic field, such as the capacity of magnesium to replace calcium in the bone structure due to their chemical similarity [15]; magnesium ions assure a better stimulation of native bone formation [16,17]; higher dissolution rates and thus higher biodegradability of magnesium phosphates [13]; magnesium ions prevent the hydroxyapatite undesired crystallization [18]. Despite these multiple advantages of using magnesium phosphate for bone-related applications, the research is still limited.
Several types of nanoparticles and nanocarriers have been validated as suitable options for limiting infection occurrence, including antibiotic-resistant ones [19,20,21,22,23,24]. Due to their well-known and long use as antimicrobial potential and unique combination of magnetic, optic, and electric properties, silver nanoparticles (AgNPs) have become very popular in the biomedical field [25]. AgNPs have many advantages over conventional antibiotics, making them a promising choice for obtaining bioactive coatings able to release locally antimicrobial species. AgNPs have good stability in the physiological environment, they exhibit microbicidal effects on a broad spectrum of microbial species, and due to their multiple molecular targets, the risk for selecting resistance is low [18]. By killing the microbial cells from the implanted material surrounding tissues and thus, inhibiting the microbial adherence and biofilm development, these coatings will minimize the risk of implant-associated infections [26,27,28,29]. They can be synthesized using various chemical, biological, electrochemical, or ‘green’ methods [26,27,30,31,32,33]. The AgNPs can be deposited on the implant surface by different approaches, aiming to achieve an acceptable balance between their cytotoxicity and antimicrobial effect [34].
Loading of AgNPs into the calcium or magnesium ceramics porous structure has been proposed to obtain biomaterials or implant coatings with high biocompatibility and antibacterial properties [35,36].
We report here the combined use of magnesium phosphate and AgNPs for developing nanostructured functional coatings with anti-adherent properties to avoid bacterial cell adhesion, spread, and growth, and to simultaneously stimulate bone regeneration. We have used the Matrix-Assisted Pulsed Laser Evaporation (MAPLE) technique to deposit the bioactive thin films on the implant material surface for obtaining homogenous coatings.
The AgNPs were obtained by chemical reduction, while Mg3(PO4)2 was synthesized by the cooling bath reaction, as both methods are characterized by high efficiencies and reaction yields [37]. The MAPLE technique allowed us to control the properties of the coatings in terms of size, rugosity, and thickness, which makes them suitable for implant coating development [38,39]. The presence of AgNPs provided the obtained coatings with antimicrobial properties, while Mg3(PO4)2 contributed its good biocompatibility, high biodegradability rate, and the capacity of interaction with osteoblasts that will lead to a faster implant integration.

2. Results and Discussion

The present study aimed to develop nanostructured coatings for orthopedic implant applications that would concomitantly ensure a bone regenerative potential through the presence of Mg3(PO4)2 and an antimicrobial character by adding AgNPs. There are many studies focused on magnetite [40,41,42,43,44,45,46], hydroxyapatite [47,48,49,50], and silver [51,52] nanoparticles for coatings obtained by MAPLE technique; no available studies report the combined use of AgNPs and Mg3(PO4)2. The characterization of the biomaterials involved the physicochemical analyses of AgNPs and Mg3(PO4)2 and the physicochemical, biological, and antimicrobial evaluation of the obtained coatings.

2.1. Physicochemical Characterization of AgNPs

AgNPs were evaluated through the XRD, TEM, and SAED techniques (Figure 1). The acquired diffractogram demonstrated the formation of silver as a unique crystalline phase in the Fm-3m cubic crystal system, as shown by the associated Miller indices (JCPDS 04-014-0266 [53]) (Figure 1a). The diffraction peaks are narrow, indicating a relatively large crystallite size. The SAED patterns further confirmed the results, as the diffraction rings correspond to the Miller indices specific for silver in the cubic system (Figure 1d). Furthermore, the crystallinity of the obtained AgNPs is demonstrated through the high intensity of the diffraction peaks within the diffractograms and by the non-diffused diffraction rings in the SAED characteristic of highly crystalline materials [54]. As can be seen in the TEM micrographs, the nanoparticles are quasispherical with an average diameter of 32.1 ± 1.1 nm and an increased tendency for agglomeration (Figure 1b).

2.2. Physicochemical Characterization of Mg3(PO4)2

Similarly, Mg3(PO4)2 was characterized using the XRD, TEM, and SAED techniques (Figure 2). The diffractogram confirms the formation of a highly crystalline Mg3(PO4)2 in the P21/n monoclinic system through the specific diffraction peaks and the associated Miller indices (JCPDS 00-033-0876 [55,56]) (Figure 2a). The SAED patterns reveal the presence of spots, which are generally characteristic of monocrystalline materials (Figure 2d). Thus, it can be stated that the Mg3(PO4)2 particles are monocrystalline, with the crystallite size corresponding to the particle size. Furthermore, TEM images reveal the formation of polyhedral particles with a uniform size of 551.81 ± 27.41 nm (Figure 2b,c).

2.3. Physicochemical Characterization of the AgNPs/Mg3(PO4)2 Coatings

The integrity of the functional groups and the composition after MAPLE deposition of the AgNPs/Mg3(PO4)2 coatings were evaluated through IR mapping. As a reference material, the drop-cast was used. The IR maps were created using the second derivative minimum of the spectral data [57]. The absorption peaks used as spectral markers are characteristic of the stretching of the P-O bond within the phosphate group at around 1100 and 800 cm−1 [58,59].
In this context, Figure 3a shows the IR micrographs of the AgNPs/Mg3(PO4)2 obtained through drop-cast. As it can be seen, the IR map shows multiple color zones, which are attributed to the amount of the AgNPs/Mg3(PO4)2 material present. As the acquired results demonstrate, the drop-cast does not provide a uniform substrate coating. However, the FT-IR results from Figure 3b can be used as reference spectra in order to assess the integrity of the functional groups. FT-IR spectra (Figure 3b) confirm the presence of PO43− at 1108 cm−1. This peak was further used to create the IR maps by monitoring its intensity. In this context, the IR mapping and FT-IR results of the coatings at three different laser fluences are depicted in Figure 4.
Furthermore, considering the complementary results from the FT-IR spectra (Figure 4a’–c’), the 200 and 300 mJ/cm2 laser fluences do not affect the integrity of the AgNPs/Mg3(PO4)2 coating chemical structures, the latter resulting in higher intensities of the absorption peaks. However, the 400 mJ/cm2 fluence led to a noticeable decrease in the absorption peak, which is associated with changes or damages to the material composition by degradation of the functional groups. Therefore, considering the obtained information, the optimal choice for further investigations is the samples processed at 300 mJ/cm2 laser fluence.
As can be seen from the obtained SEM images (Figure 5), the AgNPs/Mg3(PO4)2 coatings were uniformly deposited onto the titanium substrates. However, the top-view images (Figure 5a,b) at higher magnifications show the presence of agglomerates. The cross-section SEM images confirm the presence of agglomerates within the coatings, varying sizes from 55 nm to 300 nm. The results confirm the IR mappings, as the agglomerates present on the substrate correspond to the red-color areas from the micrographs [41,57,60].

2.4. In Vitro Evaluation

2.4.1. Osteoblasts Behavior

The morphological modifications of MC3T3-E1 osteoblasts in contact with the coatings regarding cytoskeleton organization were evaluated using fluorescence microscopy (Figure 6). The obtained results showed a positive influence of the applied coatings in terms of osteoblast layer confluency and morphology, as the cells present well-organized actin filaments and architecture specific for healthy osteoblasts as also visualized in control. It can be highlighted that these coatings were able to stimulate osteoblasts proliferation, having good biocompatibility and thus an important potential for orthopedic applications, most probably grace to Mg3(PO4)2 presence in the composition.
The MTT assay was used to examine the viability of cells grown on the surface of tested coatings (Figure 7). The obtained results suggested a high survival rate of osteoblasts seeded on the coatings, the levels of cellular viability being higher by 5% compared to control. Furthermore, no significant changes were recorded for the cells grown on the AgNPs/Mg3(PO4)2 sample, in the case of NO level and LDH release, compared to control levels (Figure 7. These results are promising, considering that recent studies show that even in low-dose, AgNPs in suspension could affect the MG-63 cells and thus interfere with bone formation [61]. Moreover, it has been shown that AgNPs exhibit their antibacterial effects at concentrations 2-4 times higher than those inducing cytotoxic effects. Generally, the cytotoxic effects against osteoblasts are directly proportional to the release of Mg ions. They occur at high concentrations, suggesting the existence of a therapeutical window for the application of AgNPs in orthopedic coatings. Still, however, a careful weighing of the anti-infective effects and good biocompatibility is needed [62,63]. One must assure by in vitro studies that the AgNPs concentrations showing antimicrobial activity are lower than the cytotoxic ones to advance with the development of useful tools to fight orthopedic implants associated infections [64]. In the coatings, the released cytotoxic species are probably below the cytotoxic concentration. Therefore, it can be concluded that the AgNPs/Mg3(PO4)2 coatings do not exhibit cytotoxicity in contact with osteoblasts and might lead to faster and uniform bone regeneration in orthopedic applications.

2.4.2. Antimicrobial Activity

Orthopedic surgery is often complicated by the occurrence of post-operative infections produced by S. aureus, other Gram-positive organisms, Gram-negative organisms including P. aeruginosa, and fungal infections, which, due to their high frequency and antimicrobial resistance features are associated with increased morbidity and mortality, decreased quality of life, and higher hospitalization costs [65,66,67]. Despite the huge technological and medical progress, the incidence of implant-associated infections is increasing proportionally to the number of patients needing implant devices [68]. A very recent retrospective study assessing the 180-day incidence of S. aureus infections in adult patients undergoing orthopedic surgery between 2010 and 2015 has shown that among the Gram-positive bacterial strains, S. aureus remains the most common pathogen isolated from culture-confirmed surgical site infections (48.0%) and bloodstream infections (35.0%), followed at a distance by Enterobacteriaceae (14.0%). This suggests that S. aureus infections continue to be an important contributor to the incidence and burden of orthopedic surgeries [69].
Although the Gram-negative bacteria are isolated with a lower frequency from orthopedic implants associated infections, they remain in the research focus due to their high resistance to currently available antimicrobials, leading to complicated, persistent infections requiring longer hospitalization and higher costs, especially in case of immunocompromised patients [70]. Among the Gram-negative bacterial species, P. aeruginosa is considered one of the most fearful and difficult to treat because of its multiple drug resistance and ability to develop biofilms and persist in different environments [71].
Our study aimed to obtain coatings consisting of AgNPs and Mg3(PO4)2 on titanium surfaces by MAPLE technique. As far as we know, the research conducted related to the decoration of magnesium phosphate with AgNPs is still scarce [36].
Our models for evaluating the antimicrobial potential of the obtained coatings were represented by S. aureus and P. aeruginosa strains, which were incubated in the presence of the samples for 48 h. The antibacterial effects of the coatings were quantified after 24 h and 48 h of incubation by assessing the number of viable cell counts. A drastic inhibition of the bacterial growth was recorded for the samples compared to controls, represented by the bare glass (Figure 8). If for the controls, the number of viable cell counts reached ~1 × 1011 and ~1 × 1013 CFU/mL at 24 h and 48 h, respectively, in the presence of AgNPs/Mg3(PO4)2 coatings considerably decreased values of ~1 × 105 CFU/mL were recorded after 24 h of incubation and maintained until 48 h.
This strong antibacterial effect could be mediated by two mechanisms, i.e., direct contact killing and Ag ion-mediated killing [29].
The direct killing is caused by the adhesion of AgNPs to the bacterial wall and eventually by the penetration of the cellular membrane by the smaller size NPs, where they can interact directly with different intracellular targets or affect them indirectly by stimulating the release of reactive oxygen species (ROS), leading to structural and physiological alterations, incompatible with the microbial cell viability. The release of silver ions from the coatings leads to their interaction mainly with membrane proteins, resulting in their inactivation, but also with nucleic acids, inhibiting DNA replication and, thus, cellular multiplication [72]. These two mechanisms could act synergistically in the cause of our functional coatings.
Despite literature data showing that AgNPs exhibit a stronger bactericidal effect against Gram-negative bacteria, due to their thinner peptidoglycan layer and the presence of a negatively charged outer membrane, favoring the interaction with the positively charged Ag ions [73], no significant differences were observed in the efficacy of the obtained coatings against the two bacterial strains, thus proving the antibacterial effect of the coatings against Gram-positive and Gram-negative bacteria.
Thus, by corroborating the in vitro cytocompatibility and antimicrobial assays results, we could state that the proposed materials exhibit a well-balanced antibacterial effect and biocompatibility, showing promising potential for orthopedic applications.

3. Materials and Methods

3.1. Materials

Silver nitrate (AgNO3), D-glucose (C₆H₁₂O₆), magnesium chloride hexahydrate (MgCl2·6H2O), phosphoric acid (H3PO4), sodium hydroxide (NaOH), and dimethyl sulfoxide (99%, DMSO) were purchased from Sigma-Aldrich Merck (Darmstadt, Germany). All chemicals were of analytical purity and used with no further purification.

3.2. Synthesis Methods

3.2.1. AgNPs Synthesis

AgNPs were prepared by chemical reduction. 0.5 g of AgNO3 was dissolved in 100 mL of deionized water. The solution containing the reduction agent was prepared by dissolving 1 g of D-glucose and 4 g of NaOH in 100 mL of deionized water under magnetic stirring at 80 °C. The second solution was added dropwise in the AgNO3 solution, which resulted in a homogenous final product that was filtered and washed with deionized water. Subsequently, the obtained product was dried.

3.2.2. Mg3(PO4)2 Synthesis

The synthesis of Mg3(PO4)2 involved the preparation of two solutions by dissolving MgCl2·6H2O and H3PO4 in 200 mL of deionized water. The H3PO4 solution was added dropwise in the MgCl2·6H2O, and the pH was adjusted from 2 to 9 using NaOH. The obtained dispersion was subjected to a cooling bath reaction for 24 h. Afterward, the obtained gel was filtered, washed, and dried at room temperature, followed by calcination at 850 °C for 6 h.

3.2.3. Coatings Fabrication by MAPLE Technique

MAPLE targets were prepared by freezing at liquid nitrogen temperature a solution of 4% (w/v) AgNPs and Mg3(PO4)2 (1:3 wt%)in DMSO. A KrF* (λ = 248 nm, τFWHM = 25 ns) (COMPexPro 205 Lambda Physics-Coherent) excimer laser beam impinged the target at a laser fluence of 200–400 mJ/cm2, the repetition rate of 20 Hz and for 79,000–138,000 pulses. During the laser irradiation, the cryogenic target was maintained at a temperature of ∼173 K by constant cooling with liquid nitrogen, rotated at a rate of 0.4 Hz, and upheld at a 4 cm distance from substrates. All depositions on the titanium disks were conducted at room temperature and a background pressure of 10−2 mbar.

3.3. Characterization Methods

X-ray Diffraction (XRD). AgNPs and Mg3(PO4)2 were subjected to the XRD analysis using a PANalytical Empyrean diffractometer (PANalytical, Almelo, The Netherlands) provided with CuKα radiation (λ = 1.541874 Å), a hybrid 2 × Ge (220) monochromator for Cu, and a parallel plate collimator on the PIXcel3D detector. Experimental data were acquired between the 2θ angles of 10-80° (incidence angle of 0.5°, step size of 0.04°, and time step of 3 s). The results were processed using the HighScore Plus software (version 3.0, PANalytical, Almelo, The Netherlands).
Transmission Electron Microscopy (TEM). Selected Area Electron Diffraction (SAED). Samples were dispersed into deionized water using an ultrasonic bath, and 10 µL of each suspension was placed on a 400-mesh lacey carbon-coated copper grid at room temperature. TEM micrographs and SAED patterns were obtained using a High-Resolution 80–200 TITAN THEMIS transmission microscope (purchased from FEI, Hillsboro, OR, USA) equipped with an Image Corrector and EDXS detector in the column that is operated at 200 kV in transmission mode.
Scanning Electron Microscopy (SEM). An Inspect F50 high-resolution scanning electron microscope (Thermo Fisher—former FEI, Eindhoven, The Netherlands) was used to assess the morphology and size of the samples at an energy of 30 keV.
Infrared Microscopy (IRM). IRM was performed with a Nicolet iN10 MX FT-IR microscope with an MCT liquid nitrogen cooled detector. The spectral collection was made in the 4000–800 cm−1 range at a resolution of 8 cm−1 in reflection mode. A total of 32 scans were co-added and converted to absorbance for each spectrum using OmincPicta software (Thermo Scientific, Waltham, MA, USA).
In vitro testing of coatings interaction with osteoblasts cells. Murine osteoblast cells (MC3T3-E1 cell line from American Type Cell Culture) were used to assess the in vitro performance of the coatings. Before testing, all samples were subjected to UV sterilization for 1 h. To determine the cellular viability, the cells were seeded on the coatings at a density of 5 × 104 cells/cm2 and kept in the incubator at 37 °C in a humid atmosphere with 5% CO2. Glass slides without nanocoating on the surface were used as control. After that, the cell culture medium was taken for the Griess assay to measure the nitric oxide (NO) level and for the lactate dehydrogenase (LDH) release assay. Firstly, the Griess reagent, represented by a stoichiometric solution (v/v) of 0.1% naphthyl ethylenediamine dihydrochloride and 1% sulphanilamide in 5% H3PO4, was mixed in equal volumes with the cell culture supernatants. The absorbance of the mix was read at 550 nm using the Tecan Genios microplate reader. Secondly, the amount of released LDH was measured with a cytotoxicity detection kit from Roche, reading the absorbance of the final mix at 450 nm.
The attached cells that remained after medium removal were incubated for 2 h with (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide solution (1 mg/mL prepared in PBS). The formazan crystals were solubilized with isopropanol, and the absorbance was spectrophotometrically measured at the 595 nm wavelength using a Tecan Genios microplate reader.
Moreover, an Olympus IX71 fluorescence inverted microscope was utilized to evaluate the actin filaments stained with phalloidin-fluorescein isothiocyanate (phalloidin-FITC) after a fixation step with 4% paraformaldehyde and a permeabilization step with 0.5% Triton X-100 and 1% bovine serum albumin. Nuclei were counterstained with 4’,6-diamidino-2-phenylindole (DAPI).
Antimicrobial Performance. The obtained coatings were evaluated in terms of antimicrobial performance and biofilm inhibition. All samples were sterilized using UV exposure for 20 min on each side. The bacterial species used for the antimicrobial evaluation were S. aureus and Ps. aeruginosa. A cellular suspension was obtained according to specific protocols to quantify the number of units that can form bacterial colonies (CFU/mL) [74].

4. Conclusions

The present study aimed to develop a series of biocompatible and antibacterial coatings that can be used in orthopedic applications. The investigated materials consisted of AgNPs and Mg3(PO4)2, which were synthesized through well-known routes and combined for obtaining nanostructured coatings by the MAPLE technique. Our study demonstrated the efficiency of the AgNPs/Mg3(PO4)2 coatings’ efficiency in promoting osteoblast viability and proliferation while exhibiting antibacterial activity against two of the most important etiological agents of orthopedic implants associated infections. Specifically, the potential of the proposed materials resides in the synergistic effects of Mg3(PO4)2 to ensure bone regeneration and implant integration, while AgNPs provide the antibacterial properties of the composite materials.

Author Contributions

Conceptualization, D.A.F., V.G., A.M.G., E.A., M.C.C.; methodology, V.G., A.M.G., E.A., M.C.C.; validation, V.G., M.C.C., C.C., M.S.S.; formal analysis, D.A.F., A.C.B., M.M., B.Ș.V., C.C., M.S.S.; investigation, D.A.F., V.G., A.C.B., M.M., B.Ș.V., A.M.G., M.C.C., C.C., M.S.S.; resources, V.G., E.A., M.C.C.; writing—original draft preparation, D.A.F., A.C.B., B.Ș.V., A.M.G., E.A., M.C.C.; writing—review and editing, A.M.G., E.A., M.C.C.; supervision, A.M.G., M.C.C.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We acknowledge the support of the project C1.2. PFE- CDI.2021-587/contract number 41PFE/2021 awarded to M.C.C.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yu, X.; Tang, X.; Gohil, S.V.; Laurencin, C.T. Biomaterials for Bone Regenerative Engineering. Adv. Healthc. Mater. 2015, 4, 1268–1285. [Google Scholar] [CrossRef] [PubMed]
  2. Jayash, S.N.; Al-Namnam, N.M.; Shaghayegh, G. Osteoprotegerin (OPG) pathways in bone diseases and its application in therapeutic perspectives. Biointerface Res. Appl. Chem. 2020, 10, 5193–5200. [Google Scholar] [CrossRef]
  3. Levingstone, T.J.; Herbaj, S.; Redmond, J.; McCarthy, H.O.; Dunne, N.J. Calcium Phosphate Nanoparticles-Based Systems for RNAi Delivery: Applications in Bone Tissue Regeneration. Nanomaterials 2020, 10, 146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ansari, M. Bone tissue regeneration: Biology, strategies and interface studies. Prog. Biomater. 2019, 8, 223–237. [Google Scholar] [CrossRef] [Green Version]
  5. van Vugt, T.A.; Geurts, J.A.P.; Arts, J.J.; Lindfors, N.C. 3—Biomaterials in treatment of orthopedic infections. In Management of Periprosthetic Joint Infections (PJIs); Arts, J.J.C., Geurts, J., Eds.; Woodhead Publishing: Sawston, UK, 2017; pp. 41–68. [Google Scholar]
  6. Burnell, J.M.; Teubner, E.J.; Miller, A.G.J.C.T.I. Normal maturational changes in bone matrix, mineral, and crystal size in the rat. Calcif. Tissue Int. 1980, 31, 13–19. [Google Scholar] [CrossRef]
  7. Maguire, M.E.; Cowan, J.A. Magnesium chemistry and biochemistry. Biometals 2002, 15, 203–210. [Google Scholar] [CrossRef]
  8. Faisal, N. Mechanical Behavior of Nano-Scaled Graphene Oxide Reinforced High-Density Polymer Ethylene for Orthopedic Implants. Biointerface Res. Appl. Chem. 2020, 10, 7223–7233. [Google Scholar] [CrossRef]
  9. Massit, A.; El Yacoubi, A.; Kholtei, A.; El Idrissi, B.C. XRD and FTIR Analysis of Magnesium Substituted Tricalcium Calcium Phosphate Using a Wet Precipitation Method. Biointerface Res. Appl. Chem. 2021, 11, 8034–8042. [Google Scholar] [CrossRef]
  10. Massit, A.; El Yacoubi, A.; Rezzouk, A.; El Idrissi, B.C. Thermal Behavior of Mg-Doped Calcium-Deficient Apatite and Stabilization of beta Tricalcium Phosphate. Biointerface Res. Appl. Chem. 2020, 10, 6837–6845. [Google Scholar] [CrossRef]
  11. Nabiyouni, M.; Brückner, T.; Zhou, H.; Gbureck, U.; Bhaduri, S.B. Magnesium-based bioceramics in orthopedic applications. Acta Biomater. 2018, 66, 23–43. [Google Scholar] [CrossRef]
  12. Razzaque, M.S.J. Magnesium: Are we consuming enough? Nutrients 2018, 10, 1863. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Marinella, M.A. The refeeding syndrome and hypophosphatemia. J. Intensive Care Med. 2003, 61, 320–323. [Google Scholar] [CrossRef] [PubMed]
  14. Barbagallo, M.; Veronese, N.; Dominguez, L.J.J.N. Magnesium in aging, health and diseases. Nutients 2021, 13, 463. [Google Scholar] [CrossRef] [PubMed]
  15. Diba, M.; Tapia, F.; Boccaccini, A.R.; Strobel, L.A.J. Magnesium-containing bioactive glasses for biomedical applications. Int. J. Appl. Glass Sci. 2012, 3, 221–253. [Google Scholar] [CrossRef]
  16. Willumeit, R.; Möhring, A.; Feyerabend, F. Optimization of cell adhesion on mg based implant materials by pre-incubation under cell culture conditions. Int. J. Mol. Sci. 2014, 15, 7639–7650. [Google Scholar] [CrossRef] [Green Version]
  17. Staiger, M.P.; Pietak, A.M.; Huadmai, J.; Dias, G.J.B. Magnesium and its alloys as orthopedic biomaterials: A review. Int. J. Mol. Sci. 2006, 27, 1728–1734. [Google Scholar] [CrossRef]
  18. Sikder, P.; Bhaduri, S.B.; Ong, J.L.; Guda, T. Silver (Ag) doped magnesium phosphate microplatelets as next-generation antibacterial orthopedic biomaterials. J. Biomed. Mater. Res. 2020, 108, 976–989. [Google Scholar] [CrossRef]
  19. Worthley, L.; Baker, S. The essentials of calcium, magnesium and phosphate metabolism: Part I. Physiology. Crit. Care Resusc. 2002, 4, 301–306. [Google Scholar]
  20. Florea, D.A.; Albuleț, D.; Grumezescu, A.M.; Andronescu, E. Surface modification—A step forward to overcome the current challenges in orthopedic industry and to obtain an improved osseointegration and antimicrobial properties. Mater. Chem. Phys. 2020, 243, 122579. [Google Scholar] [CrossRef]
  21. Wolf, F.I.; Cittadini, A. Chemistry and biochemistry of magnesium. Mol. Asp. Med. 2003, 24, 3–9. [Google Scholar] [CrossRef]
  22. Aydın, M.; Azak, E.; Bilgin, H.; Menekse, S.; Asan, A.; Mert, H.T.E.; Yulugkural, Z.; Altunal, L.N.; Hatipoğlu, Ç.A.; Ertem, G.T.J.; et al. Changes in antimicrobial resistance and outcomes of health care–associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 2021, 40, 1737–1742. [Google Scholar] [CrossRef]
  23. Esmaili, F.; Sanei-Dehkordi, A.; Amoozegar, F.; Osanloo, M. A Review on the Use of Essential Oil-Based Nanoformulations in Control of Mosquitoes. Biointerface Res. Appl. Chem. 2021, 11, 12516–12529. [Google Scholar] [CrossRef]
  24. Gounden, S.; Daniels, A.; Singh, M. Chitosan-Modified Silver Nanoparticles Enhance Cisplatin Activity in Breast Cancer Cells. Biointerface Res. Appl. Chem. 2021, 11, 10572–10584. [Google Scholar] [CrossRef]
  25. Rodrigues, A.G.; Ruiz, R.D.; Selari, P.; de Araujo, W.L.; de Souza, A.O. Anti-Biofilm Action of Biological Silver Nanoparticles Produced by Aspergillus tubingensis and Antimicrobial Activity of Fabrics Carrying it. Biointerface Res. Appl. Chem. 2021, 11, 14764–14774. [Google Scholar] [CrossRef]
  26. Thiruvengadam, V.; Bansod, A.V. Characterization of Silver Nanoparticles Synthesized using Chemical Method and its Antibacterial Property. Biointerface Res. Appl. Chem. 2020, 10, 7257–7264. [Google Scholar] [CrossRef]
  27. Tyagi, P.K.; Mishra, R.; Khan, F.; Gupta, D.; Gola, D. Antifungal Effects of Silver Nanoparticles Against Various Plant Pathogenic Fungi and its Safety Evaluation on Drosophila melanogaster. Biointerface Res. Appl. Chem. 2020, 10, 6587–6596. [Google Scholar] [CrossRef]
  28. Samberg, M.; Monteiro-Riviere, N. Silver Nanoparticles in Biomedical Applications. In Nanotoxicology, 2nd ed.; Taylor & Francis Group: Abingdon, UK, 2014; pp. 405–422. ISBN 9780429171420. [Google Scholar]
  29. Qing, Y.; Cheng, L.; Li, R.; Liu, G.; Zhang, Y.; Tang, X.; Wang, J.; Liu, H.; Qin, Y. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int. J. Nanomed. 2018, 13, 3311–3327. [Google Scholar] [CrossRef] [Green Version]
  30. Šileikaitė, A.; Prosyčevas, I.; Puišo, J.; Juraitis, A.; Guobienė, A.J.M.S. Analysis of silver nanoparticles produced by chemical reduction of silver salt solution. Mater. Sci. 2006, 12, 287–291. [Google Scholar]
  31. Vorobyova, S.; Lesnikovich, A.; Sobal, N.J.C.; Physicochemical, S.A.; Aspects, E. Preparation of silver nanoparticles by interphase reduction. Colloids Surf. A Physicochem. Eng. Asp. 1999, 152, 375–379. [Google Scholar] [CrossRef]
  32. Li, Z.; Li, Y.; Qian, X.-F.; Yin, J.; Zhu, Z.-K. A simple method for selective immobilization of silver nanoparticles. Appl. Surf. Sci. 2005, 250, 109–116. [Google Scholar] [CrossRef]
  33. Jabbar, A.H.; Al-janabi, H.S.O.; Hamzah, M.; Mezan, S.; Tumah, A.; Ameruddin, A.J. Green Synthesis and Characterization of Silver Nanoparticle (AgNPs) using Pandanus Atrocarpus Extract. Int. J. Adv. Sci. Technol. 2020, 29, 4913–4922. [Google Scholar]
  34. Wang, J.; Li, J.; Guo, G.; Wang, Q.; Tang, J.; Zhao, Y.; Qin, H.; Wahafu, T.; Shen, H.; Liu, X.; et al. Silver-nanoparticles-modified biomaterial surface resistant to staphylococcus: New insight into the antimicrobial action of silver. Sci. Rep. 2016, 6, 32699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Alqarni, A.S.; Hussin, R.; Alamri, S.N.; Ghoshal, S.K. Customized physical and structural features of phosphate-based glass-ceramics: Role of Ag nanoparticles and Ho3+ impurities. J. Taibah Univ. Sci. 2020, 14, 954–962. [Google Scholar] [CrossRef]
  36. Bee, S.-L.; Bustami, Y.; Ul-Hamid, A.; Lim, K.; Abdul Hamid, Z.A. Synthesis of silver nanoparticle-decorated hydroxyapatite nanocomposite with combined bioactivity and antibacterial properties. J. Mater. Sci. Mater. Med. 2021, 32, 106. [Google Scholar] [CrossRef]
  37. Tsuji, T.; Watanabe, N.; Tsuji, M. Laser induced morphology change of silver colloids: Formation of nano-size wires. Appl. Suf. Sci. 2003, 211, 189–193. [Google Scholar] [CrossRef]
  38. Stiff-Roberts, A.D.; Ge, W. Organic/hybrid thin films deposited by matrix-assisted pulsed laser evaporation (MAPLE). Appl. Phys. Rev. 2017, 4, 041303. [Google Scholar] [CrossRef]
  39. Radu, A.; Filipescu, M.; Dumitru, M.; Moldovan, A.; Dinescu, M.; Antohe, S.J.R.R.I.P. Physical properties of metal oxide nanoparticles processed as thin films by maple technique. Rom. Rep. Phys. 2020, 72, 503. [Google Scholar]
  40. Gherasim, O.; Popescu, R.C.; Grumezescu, V.; Mogoșanu, G.D.; Mogoantă, L.; Iordache, F.; Holban, A.M.; Vasile, B.Ș.; Bîrcă, A.C.; Oprea, O.-C.; et al. MAPLE Coatings Embedded with Essential Oil-Conjugated Magnetite for Anti-Biofilm Applications. Materials 2021, 14, 1612. [Google Scholar] [CrossRef]
  41. Grumezescu, V.; Negut, I.; Grumezescu, A.M.; Ficai, A.; Dorcioman, G.; Socol, G.; Iordache, F.; Truşcă, R.; Vasile, B.S.; Holban, A.M. MAPLE fabricated coatings based on magnetite nanoparticles embedded into biopolymeric spheres resistant to microbial colonization. Appl. Surf. Sci. 2018, 448, 230–236. [Google Scholar] [CrossRef]
  42. Grumezescu, V.; Holban, A.M.; Iordache, F.; Socol, G.; Mogoşanu, G.D.; Grumezescu, A.M.; Ficai, A.; Vasile, B.Ş.; Truşcă, R.; Chifiriuc, M.C.; et al. MAPLE fabricated magnetite@eugenol and (3-hidroxybutyric acid-co-3-hidroxyvaleric acid)–polyvinyl alcohol microspheres coated surfaces with antimicrobial properties. Appl. Surf. Sci. 2014, 306, 16–22. [Google Scholar] [CrossRef]
  43. Visan, A.I.; Popescu-Pelin, G.; Gherasim, O.; Grumezescu, V.; Socol, M.; Zgura, I.; Florica, C.; Popescu, R.C.; Savu, D.; Holban, A.M.; et al. Laser Processed Antimicrobial Nanocomposite Based on Polyaniline Grafted Lignin Loaded with Gentamicin-Functionalized Magnetite. Polymers 2019, 11, 283. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Negut, I.; Grumezescu, V.; Ficai, A.; Grumezescu, A.; Holban, A.; Popescu, R.C.; Savu, D.; Vasile, B.; Socol, G. MAPLE deposition of Nigella sativa functionalized Fe 3 O 4 nanoparticles for antimicrobial coatings. Appl. Surf. Sci. 2018, 455. [Google Scholar] [CrossRef]
  45. Holban, A.M.; Grumezescu, A.M.; Saviuc, C. Magnetite Nanocomposites Thin Coatings Prepared by MAPLE to Prevent Microbial Colonization of Medical Surfaces; Springer: New Delhi, India, 2015. [Google Scholar]
  46. Grumezescu, V.; Andronescu, E.; Holban, A.M.; Mogoanu, L.i.; Mogq anu, G.D.; Grumezescu, A.M.; Stanculescu, A.I.; Socol, G.; Iordache, F.; Maniu, H.; et al. MAPLE fabrication of thin films based on kanamycin functionalized magnetite nanoparticles with anti-pathogenic properties. Appl. Surf. Sci. 2015, 336, 188–195. [Google Scholar] [CrossRef]
  47. Rădulescu, D.; Grumezescu, V.; Andronescu, E.; Holban, A.M.; Grumezescu, A.M.; Socol, G.; Oprea, A.E.; Rădulescu, M.; Surdu, A.; Trusca, R.; et al. Biocompatible cephalosporin-hydroxyapatite-poly(lactic-co-glycolic acid)-coatings fabricated by MAPLE technique for the prevention of bone implant associated infections. Appl. Surf. Sci. 2016, 374, 387–396. [Google Scholar] [CrossRef]
  48. Gherasim, O.; Grumezescu, A.M.; Grumezescu, V.; Negut, I.; Dumitrescu, M.F.; Stan, M.S.; Nica, I.C.; Holban, A.M.; Socol, G.; Andronescu, E. Bioactive Coatings Based on Hydroxyapatite, Kanamycin, and Growth Factor for Biofilm Modulation. Antibiotics 2021, 10, 160. [Google Scholar] [CrossRef]
  49. Visan, A.; Stan, G.; Ristoscu, C.; Popescu-Pelin, G.; Sopronyi, M.; Besleaga, C.; Luculescu, C.; Chifiriuc, M.; Hussien, M.D.; Marsan, O.; et al. Combinatorial MAPLE deposition of antimicrobial orthopedic maps fabricated from chitosan and biomimetic apatite powders. Int. J. Pharm. 2016, 511, 505–515. [Google Scholar] [CrossRef] [Green Version]
  50. Rusen, L.; Brajnicov, S.; Neacsu, P.; Marascu, V.; Bonciu, A.; Dinescu, M.; Dinca, V.; Cimpean, A. Novel degradable biointerfacing nanocomposite coatings for modulating the osteoblast response. Surf. Coat. Technol. 2017, 325, 397–409. [Google Scholar] [CrossRef]
  51. Yang, S.; Zhang, J. Matrix-Assisted Pulsed Laser Evaporation (MAPLE) technique for deposition of hybrid nanostructures. Front. Nanosci. Nanotechnol. 2017, 3, 1. [Google Scholar] [CrossRef] [Green Version]
  52. Cristescu, R.; Visan, A.; Socol, G.; Surdu, A.V.; Oprea, A.E.; Grumezescu, A.M.; Chifiriuc, M.C.; Boehm, R.D.; Yamaleyeva, D.; Taylor, M.; et al. Antimicrobial activity of biopolymeric thin films containing flavonoid natural compounds and silver nanoparticles fabricated by MAPLE: A comparative study. Appl. Surf. Sci. 2016, 374, 290–296. [Google Scholar] [CrossRef]
  53. Omran, B.; Nassar, H.; Fatthallah, N.; Hamdy, A.; El-Shatoury, E.; El-Gendy, N.S. Characterization and antimicrobial activity of silver nanoparticles mycosynthesized by Aspergillus brasiliensis. J. Appl. Microbiol. 2018, 125, 370–382. [Google Scholar] [CrossRef]
  54. Chircov, C.; Bîrcă, A.C.; Grumezescu, A.M.; Vasile, B.S.; Oprea, O.; Nicoară, A.I.; Yang, C.-H.; Huang, K.-S.; Andronescu, E. Synthesis of Magnetite Nanoparticles through a Lab-On-Chip Device. Materials 2021, 14, 5906. [Google Scholar] [CrossRef] [PubMed]
  55. Farag, M.; Beherei, H.; Al-Rashidy, Z.; Farag, D.; Salem, Z. Dental pulp stem cell viability and osteogenic potential assessment of new Mg-phosphate magnetic bioceramic nanoparticles. J. Mater. Res. 2022, 37, 595–607. [Google Scholar] [CrossRef]
  56. Golafshan, N.; Vorndran, E.; Zaharievski, S.; Brommer, H.; Kadumudi, F.B.; Dolatshahi-Pirouz, A.; Gbureck, U.; van Weeren, R.; Castilho, M.; Malda, J. Tough magnesium phosphate-based 3D-printed implants induce bone regeneration in an equine defect model. Biomaterials 2020, 261, 120302. [Google Scholar] [CrossRef] [PubMed]
  57. Puiu, R.A.; Balaure, P.C.; Constantinescu, E.; Grumezescu, A.M.; Andronescu, E.; Oprea, O.-C.; Vasile, B.S.; Grumezescu, V.; Negut, I.; Nica, I.C.; et al. Anti-Cancer Nanopowders and MAPLE-Fabricated Thin Films Based on SPIONs Surface Modified with Paclitaxel Loaded β-Cyclodextrin. Pharmaceutics 2021, 13, 1356. [Google Scholar] [CrossRef] [PubMed]
  58. Touny, A.H.; Sikder, P.; Saleh, M.M.; Bhaduri, S.B. Facile synthesis and characterization of biphasic magnesium phosphate bioceramic nanosheets by a reflux approach. Mater. Res. Express 2019, 6, 095007. [Google Scholar] [CrossRef]
  59. Yu, X.; Qian, C.; Sun, L. Chemosynthesis Of Nano-Magnesium Phosphates And Its Characterization. Dig. J. Nanomater. Biostructures (DJNB) 2016, 11, 1099–1103. [Google Scholar]
  60. Niculescu, A.G.; Chircov, C.; Birca, A.C.; Grumezescu, A.M. Fabrication and Applications of Microfluidic Devices: A Review. Int. J. Mol. Sci. 2021, 22, 2011. [Google Scholar] [CrossRef]
  61. Xie, H.; Wang, P.; Wu, J. Effect of exposure of osteoblast-like cells to low-dose silver nanoparticles: Uptake, retention and osteogenic activity. Artif. Cells Nanomed. Biotechnol. 2019, 47, 260–267. [Google Scholar] [CrossRef] [Green Version]
  62. Albers, C.E.; Hofstetter, W.; Siebenrock, K.A.; Landmann, R.; Klenke, F.M. In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 2013, 7, 30–36. [Google Scholar] [CrossRef]
  63. Pauksch, L.; Hartmann, S.; Rohnke, M.; Szalay, G.; Alt, V.; Schnettler, R.; Lips, K.S. Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater. 2014, 10, 439–449. [Google Scholar] [CrossRef]
  64. Castiglioni, S.; Cazzaniga, A.; Locatelli, L.; Maier, J.A.M. Silver Nanoparticles in Orthopedic Applications: New Insights on Their Effects on Osteogenic Cells. Nanomaterials 2017, 7, 124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Wallace, W.C.; Cinat, M.E.; Nastanski, F.; Gornick, W.B.; Wilson, S.E. New epidemiology for post-operative nosocomial infections. Am. Surg. 2000, 66, 874–878. [Google Scholar] [PubMed]
  66. Razavi, M.; Shepard, D.S.; Suaya, J.A.; Stason, W.B. Postoperative Staphylococcus aureus infections in Medicare beneficiaries. PLoS ONE 2014, 9, e110133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Hardtstock, F.; Heinrich, K.; Wilke, T.; Mueller, S.; Yu, H. Burden of Staphylococcus aureus infections after orthopedic surgery in Germany. BMC Infect. Dis. 2020, 20, 233. [Google Scholar] [CrossRef] [Green Version]
  68. del Pozo, J.L.; Patel, R. The challenge of treating biofilm-associated bacterial infections. Clin. Pharmacol. Ther. 2007, 82, 204–209. [Google Scholar] [CrossRef] [PubMed]
  69. Dreyfus, J.G.; Yu, H.; Begier, E.; Gayle, J.; Olsen, M.A. Incidence and burden of Staphylococcus aureus infection after orthopedic surgeries. Infect. Control. Hosp. Epidemiol. 2022, 43, 64–71. [Google Scholar] [CrossRef]
  70. Cerioli, M.; Batailler, C.; Conrad, A.; Roux, S.; Perpoint, T.; Becker, A.; Triffault-Fillit, C.; Lustig, S.; Fessy, M.H.; Laurent, F.; et al. Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France. Front. Med. 2020, 7, 513242. [Google Scholar] [CrossRef]
  71. Pestrak, M.J.; Chaney, S.B.; Eggleston, H.C.; Dellos-Nolan, S.; Dixit, S.; Mathew-Steiner, S.S.; Roy, S.; Parsek, M.R.; Sen, C.K.; Wozniak, D.J. Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments. PLoS Pathog. 2018, 14, e1006842. [Google Scholar] [CrossRef]
  72. Siritongsuk, P.; Hongsing, N.; Thammawithan, S.; Daduang, S.; Klaynongsruang, S.; Tuanyok, A.; Patramanon, R. Two-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei. PLoS ONE 2016, 11, e0168098. [Google Scholar] [CrossRef]
  73. Abbaszadegan, A.; Ghahramani, Y.; Gholami, A.; Hemmateenejad, B.; Dorostkar, S.; Nabavizadeh, M.; Sharghi, H. The Effect of Charge at the Surface of Silver Nanoparticles on Antimicrobial Activity against Gram-Positive and Gram-Negative Bacteria: A Preliminary Study. J. Nanomater. 2015, 2015, 720654. [Google Scholar] [CrossRef] [Green Version]
  74. Caciandone, M.; Niculescu, A.-G.; Roșu, A.R.; Grumezescu, V.; Negut, I.; Holban, A.M.; Oprea, O.; Vasile, B.Ș.; Bîrcă, A.C.; Grumezescu, A.M.; et al. PEG-Functionalized Magnetite Nanoparticles for Modulation of Microbial Biofilms on Voice Prosthesis. Antibiotics 2022, 11, 39. [Google Scholar] [CrossRef] [PubMed]
Figure 1. XRD spectrum (a), TEM and HR-TEM micrographs (b,c), SAED patterns (d) and size distribution (e) of AgNPs.
Figure 1. XRD spectrum (a), TEM and HR-TEM micrographs (b,c), SAED patterns (d) and size distribution (e) of AgNPs.
Ijms 23 07910 g001aIjms 23 07910 g001b
Figure 2. XRD spectrum (a), TEM micrographs (b,c), SAED patterns (d) and size distribution (e) of Mg3(PO4)2.
Figure 2. XRD spectrum (a), TEM micrographs (b,c), SAED patterns (d) and size distribution (e) of Mg3(PO4)2.
Ijms 23 07910 g002
Figure 3. IR map (a) and FT-IR spectra (b) of AgNPs/Mg3(PO4)2 drop-cast.
Figure 3. IR map (a) and FT-IR spectra (b) of AgNPs/Mg3(PO4)2 drop-cast.
Ijms 23 07910 g003
Figure 4. IR maps (ac) and FT-IR spectra (a’c’) of AgNPs/Mg3(PO4)2 coatings obtained by MAPLE tehnicque at 200 mJ/cm2 (a,a’), 300 mJ/cm2 (b,b’), and 400 mJ/cm2 (c,c’) laser fluences.
Figure 4. IR maps (ac) and FT-IR spectra (a’c’) of AgNPs/Mg3(PO4)2 coatings obtained by MAPLE tehnicque at 200 mJ/cm2 (a,a’), 300 mJ/cm2 (b,b’), and 400 mJ/cm2 (c,c’) laser fluences.
Ijms 23 07910 g004aIjms 23 07910 g004b
Figure 5. Top-view SEM images (a,b) and Cross-section SEM images (c,d) of the AgNPs/Mg3(PO4)2 coatings at different magnifications.
Figure 5. Top-view SEM images (a,b) and Cross-section SEM images (c,d) of the AgNPs/Mg3(PO4)2 coatings at different magnifications.
Ijms 23 07910 g005aIjms 23 07910 g005b
Figure 6. Fluorescence microscopy images for actin filaments (green) and nuclei (blue) staining in MC3T3-E1 osteoblasts grown for 24 h on the surface of control (a), and AgNPs/Mg3(PO4)2 (b) coatings.
Figure 6. Fluorescence microscopy images for actin filaments (green) and nuclei (blue) staining in MC3T3-E1 osteoblasts grown for 24 h on the surface of control (a), and AgNPs/Mg3(PO4)2 (b) coatings.
Ijms 23 07910 g006
Figure 7. Cell viability, NO level, and LDH release after 24-h growth of MC3T3-E1 osteoblasts on the surface of control and AgNPs/Mg3(PO4)2 coatings.
Figure 7. Cell viability, NO level, and LDH release after 24-h growth of MC3T3-E1 osteoblasts on the surface of control and AgNPs/Mg3(PO4)2 coatings.
Ijms 23 07910 g007
Figure 8. Antibacterial efficiency assessment of the AgNPs/Mg3(PO4)2 coatings against S. aureus (a) and P. aeruginosa (b) at 24 and 48 h.
Figure 8. Antibacterial efficiency assessment of the AgNPs/Mg3(PO4)2 coatings against S. aureus (a) and P. aeruginosa (b) at 24 and 48 h.
Ijms 23 07910 g008
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Florea, D.A.; Grumezescu, V.; Bîrcă, A.C.; Vasile, B.Ș.; Mușat, M.; Chircov, C.; Stan, M.S.; Grumezescu, A.M.; Andronescu, E.; Chifiriuc, M.C. Design, Characterization, and Antibacterial Performance of MAPLE-Deposited Coatings of Magnesium Phosphate-Containing Silver Nanoparticles in Biocompatible Concentrations. Int. J. Mol. Sci. 2022, 23, 7910. https://doi.org/10.3390/ijms23147910

AMA Style

Florea DA, Grumezescu V, Bîrcă AC, Vasile BȘ, Mușat M, Chircov C, Stan MS, Grumezescu AM, Andronescu E, Chifiriuc MC. Design, Characterization, and Antibacterial Performance of MAPLE-Deposited Coatings of Magnesium Phosphate-Containing Silver Nanoparticles in Biocompatible Concentrations. International Journal of Molecular Sciences. 2022; 23(14):7910. https://doi.org/10.3390/ijms23147910

Chicago/Turabian Style

Florea, Denisa Alexandra, Valentina Grumezescu, Alexandra Cătălina Bîrcă, Bogdan Ștefan Vasile, Mihaela Mușat, Cristina Chircov, Miruna S. Stan, Alexandru Mihai Grumezescu, Ecaterina Andronescu, and Mariana Carmen Chifiriuc. 2022. "Design, Characterization, and Antibacterial Performance of MAPLE-Deposited Coatings of Magnesium Phosphate-Containing Silver Nanoparticles in Biocompatible Concentrations" International Journal of Molecular Sciences 23, no. 14: 7910. https://doi.org/10.3390/ijms23147910

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop